|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 18.46 USD | 0.00% |
|
+0.11% | +1.26% |
| 09-21 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 09-18 | Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET Predictor | MT |
Company Valuation: Simulations Plus, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: August | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 891.9 | 1,215 | 886.5 | 725.3 | 285.2 | 373.4 | - | - |
| Change | - | 36.24% | -27.04% | -18.19% | -60.68% | 30.91% | - | - |
| Enterprise Value (EV) | 891.9 | 1,215 | 886.5 | 725.3 | 285.2 | 373.4 | 373.4 | 373.4 |
| Change | - | 36.24% | -27.04% | -18.19% | -60.68% | 30.91% | 0% | 0% |
| P/E | 94.3x | 100x | 90.8x | 74x | -4.4x | 44x | 40.3x | - |
| PBR | - | 6.83x | - | - | - | - | - | - |
| PEG | - | 3.6x | -5x | - | 0x | -0x | 4.51x | - |
| Capitalization / Revenue | 19.2x | 22.5x | 14.9x | 10.4x | 3.6x | 4.56x | 4.33x | 3.87x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.56x | 4.33x | 3.87x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 15.9x | 14.9x | - |
| EV / EBIT | 0x | 0x | 0x | 0x | -0x | 31.8x | 31.6x | 23.5x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 42.9x | 47x | 28.7x |
| FCF Yield | 1.97% | 1.41% | 2.41% | 1.76% | 5.18% | 2.33% | 2.13% | 3.48% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.47 | 0.6 | 0.49 | 0.49 | -3.22 | 0.42 | 0.4575 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 46.47 | 53.91 | 59.58 | 70.01 | 79.18 | 81.87 | 86.26 | 96.46 |
| EBITDA 1 | 14.84 | 21 | 20.6 | 20.3 | 21.97 | 23.45 | 25.04 | - |
| EBIT 1 | 11.25 | 14.91 | 8.725 | 6.131 | -70.73 | 11.72 | 11.8 | 15.92 |
| Net income 1 | 9.782 | 12.48 | 9.961 | 9.954 | -64.72 | 9.534 | 10.18 | - |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 44.30 | 60.05 | 44.49 | 36.25 | 14.17 | 18.46 | 18.46 | 18.46 |
| Nbr of stocks (in thousands) | 20,133 | 20,236 | 19,927 | 20,008 | 20,127 | 20,225 | - | - |
| Announcement Date | 10/25/21 | 10/26/22 | 10/25/23 | 10/23/24 | 12/1/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 43.95x | - | - | - | 373M | |
| 42.97x | 10.4x | 22.93x | -.--% | 45.44B | |
| 89.81x | 48.8x | 61.96x | 0.59% | 11.81B | |
| 73.6x | 12.79x | 50.3x | 0.7% | 5.54B | |
| -65.14x | 16.54x | -108.31x | - | 4.28B | |
| -6.5x | 57.52x | -6.52x | - | 1.94B | |
| 34.23x | - | - | -.--% | 1.54B | |
| -119.08x | - | - | - | 1.01B | |
| 6.68x | - | - | - | 960M | |
| Average | 11.17x | 29.21x | 4.07x | 0.32% | 8.1B | |
| Weighted average by Cap. | 42.33x | 18.87x | 22.85x | 0.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SLP Stock
- Valuation Simulations Plus, Inc.
Select your edition
All financial news and data tailored to specific country editions
